Inhibition of EGFR signaling: all mutations are not created equal.
Gazdar
Adi F
AF
Hamon Center for Therapeutic Oncology Research and in the Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. adi.gazdar@utsouthwestern.edu
Minna
John D
JD
D066246:ErbB Receptors / Q000235:genetics* / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases